Authors
Latest:
Bidirectionality of the Relaunched Myasthenia Gravis Patient Registry: Paul Strumph, MDThe lead of the Myasthenia Gravis Foundation of America Global Myasthenia Gravis Patient Registry spoke on 2 additional attributes of the patient registry. [WATCH TIME: 3 minutes]
Latest:
Multiple Sclerosis Care During a PandemicJoin Ahmed Obeidat, MD, PhD; Anne Cross, MD; and Gloria von Geldern, MD, for the third program in this series, where they offer insight from neurology specialists on applying lessons learned from the COVID-19 pandemic into clinical practice when managing patients with multiple sclerosis.
Latest:
Addressing the Greatest Needs in ALS: Calaneet Balas, MSc, MBAThe president and chief executive officer of The ALS Association provided insight on the most pressing needs for patients with ALS and the organization’s focus going forward. [WATCH TIME: 5 minutes]
Latest:
Raising Awareness to Improve Early Diagnosis and Treatment of Duchenne Muscular Dystrophy: Douglas Sproule, MD, MScThe chief medical officer at ML Bio Solutions, an affiliate of BridgeBio, talked about the importance of awareness for neuromuscular diseases such as Duchenne muscular dystrophy and why a timely diagnosis can make a profound difference in a patient’s life. [WATCH TIME: 3 minutes]
Latest:
Key Challenges and Future Directions of Targeting mTOR for Epileptic Disorders: Ghayda Mirzaa, MDThe principal investigator at Seattle Children’s Research Institute described some of the ongoing questions that remain with developing therapeutics that target mTOR signaling pathway in pediatric epilepsy conditions. [WATCH TIME: 3 minutes]
Latest:
Advances in Minimally Invasive Diagnostic Tests for Neurodegenerative Diseases: David Shprecher, DO, MSci, FAANThe director of movement disorders at the Banner Sun Health Research Institute talked about making strides in developing minimally invasive tests and imaging ligands for neurodegenerative diseases, such as Parkinson disease. [WATCH TIME: 2 minutes]
Latest:
Christian Meisel, MD, PhD: Treatment Landscape for Seizure Forecasting DevicesThe neurologist from Universitätsmedizin Berlin and Berlin Institute of Health provided his insight on the reasons for the limited number of FDA-approved seizure forecasting devices.
Latest:
Addressing the Current State of Care, Pipeline in NMOSD: Melanie Truong-Le, DO, ODThe neuro-ophthalmologist at UT Southwestern further discussed the high cost of treatment for patients with neuromyelitis optica spectrum disorder and the need to improve access to care.
Latest:
The Science of Sleep Health and Romantic Relationships: Wendy Troxel, PhDFor Valentine’s Day, the senior behavioral scientist at the RAND Corporation talked about the significance of sleep health and romantic relationships [WATCH TIME: 5 minutes]
Latest:
Key Insights from ACTRIMS Forum 2025: Diagnostic Criteria, Imaging, and MS SubtypesExperts discussed recent advancements in diagnostic criteria, imaging techniques, and the evolving understanding of multiple sclerosis subtypes and treatment responses. [WATCH TIME: 10 minutes]
Latest:
Transforming the Landscape of Parkinson Disease Care Through Patient-Centric FocusMichael Soileau, MD, FAAN, talked about a panel of specialists who discussed the evolution and multidisciplinary treatment of Parkinson disease, emphasizing patient-centered care and advanced therapeutic options.
Latest:
Dyskinesia and Patient Communication in Parkinson DiseasePanelists discuss how early recognition of dyskinesia symptoms, ongoing patient-clinician communication, and individualized treatment strategies are key to effectively managing Parkinson disease and improving patients’ quality of life.
Latest:
AUPN Leading Edge Episode 2: So You Want to Be a Dean? Pros, Cons, Joys and TribulationsAUPN Leading Edge Episode 2 features Clifton Gooch, MD, and Charles Lockwood, MD, who explore making the leap from chair to dean. [LISTEN TIME: 25 minutes]
Latest:
New Horizons in Multiple SclerosisExperts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.
Latest:
AUPN 2022 Spring Chairs Session: Simulations for Training in NeurologyDavid G. Standaert, MD, PhD; Wolfgang Muhlhofer, MD; and Latisha Sharma, MD, share their experience in applying simulation-based learning in Neurology and will discuss the current state and future potential of this approach. [WATCH TIME: 1 hour, 25 minutes]
Latest:
Insights on Seizure Therapy and Future Plans in Epilepsy Research: Iryna Leunikava, MScThe European evidence generation strategy lead for epilepsy and rare syndromes at UCB described some details about further epilepsy research and other explorations in the next few years. [WATCH TIME: 3 minutes]
Latest:
Challenges With Identifying Convulsive Events to Prevent Sudden Death in Toddlers: Orrin Devinsky, MDThe director of NYU Langone’s Comprehensive Epilepsy Center discussed the infrequent prevalence of febrile seizures in toddlers prior to sudden death and the difficulty with toeing the line on being overly cautious and reasonable. [WATCH TIME: 4 minutes]
Latest:
Clinical Pearls for the Management of MSExpert neurologists emphasize the importance of conversations around patient lifestyle, mental health, and comorbid conditions as keys to improve care for MS.
Latest:
Use of Long-term NMOSD Data in Clinical PracticeSean Pittock, MD, discusses how he utilizes long-term data in his clinical practice for treating neuromyelitis optica spectrum disorder and offers advice for physicians on incorporating these insights into patient care.
Latest:
Newborn Screening Awareness Month: Understanding the Impact of Newborn Screening for SMAAdvocacy organization Cure SMA provides insight on the importance of continuing to push for standardized newborn screening and how it can positively impact outcomes in SMA.
Latest:
AUPN Leadership Minute Episode 40: Funding Resident and Fellow PositionsEpisode 40 of the AUPN Leadership Minute features Clifton L. Gooch, MD, of the University of South Florida; and Tom Frontera, MD, of the University of South Florida. [WATCH TIME: 9 minutes]
Latest:
Changes in Themes Across Neurology Over the Years: Rebecca Gottesman, MD, PhD, FANA; Frances E. Jensen, MD, FACPThe president of the ANA and the chair of the annual meeting programming committee provided commentary on the advances in neurology and the shift in how clinicians approach and treat diseases once thought to be fatal. [WATCH TIME: 6 minutes]
Latest:
SARS-CoV-2 May Alter Blood-Brain Barrier FunctionThere is no evidence yet that SARS-CoV-2 can pass the blood-brain barrier, though its effects on the barrier may be intensified in those with dementia.
Latest:
Future Research Objectives and Questions for Radiologically Isolated Syndrome: Darin Okuda, MD, FAAN, FANAThe director of Neuroinnovation and Multiple Sclerosis & Neuroimmunology Imaging Program at UT Southwestern Medical Center discussed ways to build off the ARISE study and the unanswered questions regarding radiologically isolated syndrome. [WATCH TIME: 3 minutes]
Latest:
Advice for Clinicians Treating SpasticityExperts on spasticity provide advice for practicing clinicians to optimize patient outcomes.
Latest:
Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia CareLassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.
Latest:
The Endocannabinoid System and its Relationship to Migraine: Tally Largent-Milnes, PhDThe assistant professor of pharmacology at the University of Arizona College of Medicine Tucson shared her insight into the endocannabinoid system and its therapeutic potential in treating migraine. [WATCH TIME: 5 minutes]
Latest:
Lessons Learned and Future Possibilities in ALS Collaborations: Edritz Javelosa, PhDAt the 2023 MDA conference, the scientific research portfolio director at Muscular Dystrophy Association detailed a session on collaborative research in ALS and ongoing efforts in the field. [WATCH TIME: 3 minutes]
